What Xaira Therapeutics does
Xaira Therapeutics is an AI-native biotechnology company building an end-to-end drug discovery and development platform that combines (1) advanced machine learning research, (2) large-scale biological data generation, and (3) therapeutic product development across modalities. The company positions its technical differentiation around “making biology more computable” by integrating founder-led protein design capabilities from the University of Washington Institute for Protein Design into new models, while scaling causal biological datasets (e.g., CRISPRi Perturb-seq) to train “virtual cell” modeling for target-to-therapy translation. Xaira states that its AI capabilities range from foundational computational methods to applications in molecule design and clinical development, and that its internal product development process is also used to generate rich data that further improves models.